Antibacterial Agents TRIZ Cases

Simplified Teixobactin analogues bypass rare amino acid synthesis bottlenecks while slowing resistance evolution through cell wall targeting.

Conjugated p97 polypeptide fragments transport therapeutic agents across the blood-brain barrier, enabling central nervous system treatment.

Replacing toxic aluminum salts with PACAP peptide enhances vaccine effectiveness while reducing harmful inflammatory cytokine expression.

Positively charged beta-lactam prodrugs penetrate human skin via electrostatic membrane interaction.

A pharmaceutical suspension combining moxifloxacin and triamcinolone with ionic and non-ionic surfactants to maintain physical stability.

Crystalline Nap-protected intermediates simplify purification and boost yields, resolving low-yield synthesis bottlenecks in ST3 vaccine production.

Glycomimetic compounds mimic sialylated galactose receptors to block pathogen binding, bypassing the lag time of strain-specific vaccine production.

Boronic acid compounds inhibit penicillin-binding proteins via reversible covalent bonds, bypassing beta-lactamase degradation to treat resistant infections.

Aminocoumarin compounds bind bacterial gyrase to inhibit DNA supercoiling, reducing polymyxin toxicity while treating Gram-negative infections.

Merges Spy0167, Spy0269, and Spy0416 antigens to neutralize toxins and mediate bacterial killing against multiple strains.

A freeze-dried fecal microbe preparation restores gut microbial communities through oral administration.

Patchoulol inhibits methicillin-resistant Staphylococcus aureus growth, offering an alternative to vancomycin.

OligoHA treatment addresses inadequate disease control in inflammatory bowel disease by reducing dendritic cell activity and bacterial translocation.

Nano-emulsion adjuvant reduces local adverse reactions while maintaining robust immune responses against PCV2 and Mycoplasma hyopneumoniae.

Second mutations at K322 or P329 maintain stable Fc-Fc oligomerization while reducing C1q binding and FcγR interactions to decrease unwanted immune activation.

Segmented pyridine derivatives with localized substituent groups resist TBK1 and IKKε activity to resolve the lack of effective kinase inhibitors.

Triazolyl phenyl benzenesulfonamide compounds selectively block CCR2 and CCR9 receptors to reduce inflammatory responses and immune cell trafficking.

A FRET molecular construct uses a cleavable linker peptide to detect botulinum neurotoxins via optical signal changes.

Point mutations in bacteriophage K expand host range to eliminate antibiotic-resistant MRSA without chemical irritation.

Tannic acid zinc gentamicin nanoparticles bind cfDNA and scavenge ROS to reduce inflammation while avoiding systemic cytotoxicity from cationic surfaces.

O-acetylated L3 lipooligosaccharide formulation reduces toxicity while maintaining broad bactericidal immunity against diverse Neisseria meningitidis strains.

Ultrasound irradiation synthesizes imidazole derivatives using ionic liquids, eliminating hazardous solvents while maintaining high antimicrobial activity.

Microfluidic droplet platforms enable parallel processing of nanoliter volumes to identify synergistic drug combinations.

Hydroxycarboxylic acid levels reduce iodine stability in nasal antiseptics; this formulation maintains available iodine through parameter optimization.

Lactobacillus paracasei GM-080 secretes antimicrobial peptides to inhibit pathogenic bacteria, resolving antibiotic resistance side effects.

Local functionalization of the spiroketal core expands therapeutic efficacy across cancer, parasitic, and bacterial targets while managing synthesis complexity.

Deleting folate transport genes in Streptococcus suis creates an attenuated strain that induces long-lasting immunity against multiple serotypes.

Leeches extract kills bacteria via natural peptides, avoiding resistance and environmental contamination.

Penicillium menonorum transforms cellulosic sugars into triacylglycerides, reducing greenhouse gas emissions while maintaining high fuel production efficiency.

Enterococcus bacteria prevent MRSA infections by enhancing survival rates and body weight maintenance in animal models.

Specific benzimidazole derivatives target ALK1, ALK2, and ALK5 to minimize off-target effects.

A palladium-catalyzed C-H activation methodology synthesizes substituted pyrroloquinoline alkaloids with high selectivity and yield.

Substituted 6-phenylnicotinic acid derivatives resolve weak receptor interaction by enhancing metabolic stability and therapeutic efficacy.

A triple combination therapy using anti-TNFα, hyperbaric oxygen, and anti-MAP agents targets inflammation and infection in Crohn's disease.

Replacing NaCl with sorbitol prevents precipitation, enabling stable subcutaneous injection without reconstitution.

Vonoprazan acid blockers stabilize antibiotics against degradation to increase H. pylori eradication rates.

Zinc salts rapidly increase stomach pH and reduce acid release, addressing slow onset limitations of proton pump inhibitors.

Incorporating inorganic peroxide into biodegradable polymers generates oxygen to prevent necrosis in large hypoxic tissue implants.

Enzyme-sensitive molecules release carbon monoxide through intramolecular cyclization, eliminating metal toxicity and external UV light requirements.

Inhaled bedaquiline suspension targets lung tissue directly, bypassing systemic circulation to reduce side effects while maintaining therapeutic efficacy.

A topical pharmaceutical composition combines polymyxin B and trimethoprim to treat bacterial infections.

Thymosin alpha 1 activates dendritic cells to stimulate Th1 immune responses, reducing mortality in immunocompromised patients with invasive aspergillosis.

Detoxified and solubilized AcfD protein variants serve as safer immunogens for extraintestinal pathogenic Escherichia coli vaccines.

Replacing sulfate ions with chloride ions in arbekacin formulations reduces cough reactions while maintaining antibacterial efficacy.

Blood biomarker panels differentiate latent from active tuberculosis by measuring specific gene expression levels.

A Heteropyxis natalensis extract composition inhibits pathogenic microorganisms and reduces bacterial adhesion to tooth enamel.

Composite MBL inhibitors merge beta-lactam moieties with zinc chelators to restore antibiotic efficacy against resistant bacteria without cytotoxic effects.